Es­pe­ri­on sues Dai­ichi Sankyo, de­mand­ing pay­ment of $300M mile­stone for car­dio drug

Es­pe­ri­on is su­ing its busi­ness part­ner Dai­ichi Sankyo, say­ing the Japan­ese drug­mak­er is im­prop­er­ly re­fus­ing to pay a $300 mil­lion mile­stone that the biotech com­pa­ny …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER